Exosomal transfer of miR‑25‑3p promotes the proliferation and temozolomide resistance of glioblastoma cells by targeting FBXW7

Jul 19, 2021International journal of oncology

Small RNA in cell packages helps brain tumor cells grow and resist chemotherapy by affecting a key growth regulator

AI simplified

Circadian Biology on OpenScience ↗PubMed ↗DOI ↗

Abstract

Exosomal miR‑25‑3p is associated with temozolomide resistance in glioblastoma cells.

A TMZ-resistant glioblastoma cell line (A172R) was used to study exosomal microRNAs.
Exosomal transfer of miR‑25‑3p promoted proliferation and resistance to TMZ in sensitive GBM cells.
Higher levels of miR‑25‑3p were found in exosomes from A172R cells and in serum samples from GBM patients treated with TMZ.
Depleting exosomal miR‑25‑3p reduced the effects of A172R-derived exosomes on sensitive GBM cells.
FBXW7 was identified as a direct target of miR‑25‑3p, with its knockdown enhancing cell proliferation and TMZ resistance.

AI simplified

Intrinsic or acquired resistance to temozolomide (TMZ) is a frequent occurrence in patients with glioblastoma (GBM). Accumulating evidence has indicated that the exosomal transfer of proteins and RNAs may confer TMZ resistance to recipient cells; however, the potential molecular mechanisms are not fully understood. Thus, the aim of the present study was to elucidate the possible role of exosomal microRNAs (miRNAs/miRs) in the acquired resistance to TMZ in GBM. A TMZ‑resistant GBM cell line (A172R) was used, and exosomes derived from A172R cells were extracted. Exosomal miR‑25‑3p was identified as a miRNA associated with TMZ resistance. The potential functions of exosomal miR‑25‑3p were evaluated by reverse transcription‑quantitative PCR, as well as cell viability, colony formation and soft agar assay, flow cytometry, western blot analysis, BrdU incorporation assay, tumor xenograft formation, luciferase reporter assay and RNA immunoprecipitation. It was found that A172R‑derived exosomes promoted the proliferation and TMZ resistance of sensitive GBM cells. Moreover, miR‑25‑3p epxression was upregulated in the exosomes of A172R cells and in serum samples of patients with GBM treated with TMZ. The depletion of exosomal miR‑25‑3p partially abrogated the effects induced by the transfer of exosomes from A172R cells. By contrast, miR‑25‑3p overexpression facilitated the proliferation and TMZ resistance of sensitive GBM cells. F‑box and WD repeat domain‑containing‑7 (FBXW7) was identified as a direct target of miR‑25‑3p. FBXW7 knockdown promoted the proliferation and TMZ resistance of GBM cells. Furthermore, the exosomal transfer of miR‑25‑3p promoted c‑Myc and cyclin E expression by downregulating FBXW7. Our results provided a novel insight into exosomal microRNAs in acquired TMZ resistance of GBM cells. Besides, exosomal miR‑25‑3p might be a potential prognostic marker for GBM patients.

Full Text

We can’t show the full text here under this license. Use the link below to read it at the source.

View on DOI ↗View on PubMed ↗

Exosomal transfer of miR‑25‑3p promotes the proliferation and temozolomide resistance of glioblastoma cells by targeting FBXW7

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the circadian biology brief

Abstract

Full Text

Related papers

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the circadian biology brief